- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glioma and temozolomide induced alterations in gut microbiome ; volume:10 ; number:1 ; day:3 ; month:12 ; year:2020 ; pages:1-11 ; date:12.2020
Scientific reports ; 10, Heft 1 (3.12.2020), 1-11, 12.2020
- Urheber
-
Patrizz, Anthony
Dono, Antonio
Zorofchian, Soheil
Hines, Gabriella
Takayasu, Takeshi
Husein, Nuruddin
Otani, Yoshihiro
Arevalo, Octavio
Choi, H. Alex
Savarraj, Jude
Tandon, Nitin
Ganesh, Bhanu P.
Kaur, Balveen
McCullough, Louise D.
Ballester, Leomar Y.
Esquenazi, Yoshua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77919-w
- URN
-
urn:nbn:de:101:1-2021010718421597715305
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Patrizz, Anthony
- Dono, Antonio
- Zorofchian, Soheil
- Hines, Gabriella
- Takayasu, Takeshi
- Husein, Nuruddin
- Otani, Yoshihiro
- Arevalo, Octavio
- Choi, H. Alex
- Savarraj, Jude
- Tandon, Nitin
- Ganesh, Bhanu P.
- Kaur, Balveen
- McCullough, Louise D.
- Ballester, Leomar Y.
- Esquenazi, Yoshua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells
Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells
Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells
Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells